CompletedPhase 2NCT02931175
ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
Studying Infectious panuveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Quan Dong Nguyen
- Principal Investigator
- Quan D Nguyen, MD MScOcular Imaging Research and Reading Center
- Intervention
- ACTH gel(drug)
- Enrollment
- 28 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2021
Study locations (7)
- Retina Vitreous Associates, Medical Group, Los Angeles, California, United States
- Stanford University, Palo Alto, California, United States
- Metropolitan Eye Research and surgery Institute, Waltham, Massachusetts, United States
- Retina Centers Professional Corporation - RCPC, Cleveland, Ohio, United States
- Retina Consultants of Houston, Bellaire, Texas, United States
- Texas Retina Assiciates, Dallas, Texas, United States
- TExas Retina Associates, Dallas, Texas, United States
Collaborators
Mallinckrodt
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02931175 on ClinicalTrials.gov